Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO   US7142901039

PERRIGO COMPANY (PRGO)

6
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company was formed as a part of merger between Perrigo Co. and Elan Corp. Plc as on December... 
Sector
Pharmaceuticals
Calendar
02/05 | 08:00amEarnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Financials ($)
Sales 2015 4 456 M
EBIT 2015 1 292 M
Net income 2015 802 M
Debt 2015 1 158 M
Yield 2015 0,34%
Sales 2016 4 797 M
EBIT 2016 1 491 M
Net income 2016 1 011 M
Debt 2016 521 M
Yield 2016 0,34%
PER 2015 27,40
PER 2016 21,54
EV / Sales 2015 5,24x
EV / Sales 2016 4,73x
Capitalization 22 177 M
More Financials
Latest news on PERRIGO COMPANY
01/21 PERRIGO : enters gummy vitamin market
01/13 PERRIGO : inks deal with Ferrara to enter gummy vitamins and dietary supplement ..
01/07 PERRIGO : To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014 PERRIGO : Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® ..
2014 Germany's Merck aims to grow, not sell $1 billion consumer health arm
2014 PERRIGO COMPANY PLC : ex-dividend day
2014 SAC's Martoma wins delay of 9-year insider trading prison term
2014 PERRIGO : Financial Results, Appointments, and Upcoming Conference Calls - Resea..
More news
Sector news Pharmaceuticals - NEC
09:17a Stock futures tumble with Microsoft, Caterpillar; data weighs
09:00a Novartis flags faster sales and profit growth for 2015
08:37a PFIZER : net down on lower sales, higher research, legal costs
Plus d'actualités du secteur Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF